Results 1 to 10 of about 26,081 (268)

Hyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response. [PDF]

open access: yesRev Endocr Metab Disord
Hyperphagia is a hallmark of both congenital and acquired rare melanocortin-4 receptor (MC4R) pathway diseases. Currently, the medical community has no standard treatment guidelines or approach to establishing treatment benefit.
Argente J   +7 more
europepmc   +3 more sources

Natural History of Hyperphagia in Patients with Pseudohypoparathyroidism. [PDF]

open access: yesJ Clin Med
Background/Objectives: Pseudohypoparathyroidism (PHP) is a group of genetic disorders characterized by end-organ resistance to multiple hormones, short stature, brachydactyly, subcutaneous ossifications, obesity, and developmental delays.
Tamaroff J, Shoemaker AH.
europepmc   +2 more sources

A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndrome. [PDF]

open access: yesJ Clin Sleep Med
Revana A   +11 more
europepmc   +1 more source

Exploring cannabinoid receptor CB1 autophagy and the obesity phenotype of p62-deficient mice. [PDF]

open access: yesBiochem Biophys Rep
Keller C   +5 more
europepmc   +1 more source

Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts.

open access: yesJ Clin Endocrinol Metab
Tan Q   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy